Behavioral phenotypes of Disc1 missense mutations in mice - PubMed (original) (raw)
. 2007 May 3;54(3):387-402.
doi: 10.1016/j.neuron.2007.04.015.
Tatiana V Lipina, J Kirsty Millar, Shaun Mackie, Sheila Christie, Fumiaki Ogawa, Jason P Lerch, Keith Trimble, Masashi Uchiyama, Yoshiyuki Sakuraba, Hideki Kaneda, Toshihiko Shiroishi, Miles D Houslay, R Mark Henkelman, John G Sled, Yoichi Gondo, David J Porteous, John C Roder
Affiliations
- PMID: 17481393
- DOI: 10.1016/j.neuron.2007.04.015
Free article
Behavioral phenotypes of Disc1 missense mutations in mice
Steven J Clapcote et al. Neuron. 2007.
Free article
Abstract
To support the role of DISC1 in human psychiatric disorders, we identified and analyzed two independently derived ENU-induced mutations in Exon 2 of mouse Disc1. Mice with mutation Q31L showed depressive-like behavior with deficits in the forced swim test and other measures that were reversed by the antidepressant bupropion, but not by rolipram, a phosphodiesterase-4 (PDE4) inhibitor. In contrast, L100P mutant mice exhibited schizophrenic-like behavior, with profound deficits in prepulse inhibition and latent inhibition that were reversed by antipsychotic treatment. Both mutant DISC1 proteins exhibited reduced binding to the known DISC1 binding partner PDE4B. Q31L mutants had lower PDE4B activity, consistent with their resistance to rolipram, suggesting decreased PDE4 activity as a contributory factor in depression. This study demonstrates that Disc1 missense mutations in mice give rise to phenotypes related to depression and schizophrenia, thus supporting the role of DISC1 in major mental illness.
Comment in
- What is a schizophrenic mouse?
Low NC, Hardy J. Low NC, et al. Neuron. 2007 May 3;54(3):348-9. doi: 10.1016/j.neuron.2007.04.014. Neuron. 2007. PMID: 17481386
Similar articles
- Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.
Lipina TV, Wang M, Liu F, Roder JC. Lipina TV, et al. Neuropharmacology. 2012 Mar;62(3):1252-62. doi: 10.1016/j.neuropharm.2011.02.020. Epub 2011 Mar 2. Neuropharmacology. 2012. PMID: 21376063 - Comprehensive behavioral analysis of ENU-induced Disc1-Q31L and -L100P mutant mice.
Shoji H, Toyama K, Takamiya Y, Wakana S, Gondo Y, Miyakawa T. Shoji H, et al. BMC Res Notes. 2012 Feb 20;5:108. doi: 10.1186/1756-0500-5-108. BMC Res Notes. 2012. PMID: 22348257 Free PMC article. - Disrupted-in-schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression.
Lipina TV, Fletcher PJ, Lee FH, Wong AH, Roder JC. Lipina TV, et al. Neuropsychopharmacology. 2013 Feb;38(3):423-36. doi: 10.1038/npp.2012.197. Epub 2012 Sep 26. Neuropsychopharmacology. 2013. PMID: 23011268 Free PMC article. - Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness.
Millar JK, Mackie S, Clapcote SJ, Murdoch H, Pickard BS, Christie S, Muir WJ, Blackwood DH, Roder JC, Houslay MD, Porteous DJ. Millar JK, et al. J Physiol. 2007 Oct 15;584(Pt 2):401-5. doi: 10.1113/jphysiol.2007.140210. Epub 2007 Sep 6. J Physiol. 2007. PMID: 17823207 Free PMC article. Review. - Role of DISC1 in neural development and schizophrenia.
Mackie S, Millar JK, Porteous DJ. Mackie S, et al. Curr Opin Neurobiol. 2007 Feb;17(1):95-102. doi: 10.1016/j.conb.2007.01.007. Epub 2007 Jan 26. Curr Opin Neurobiol. 2007. PMID: 17258902 Review.
Cited by
- Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice.
Lee FH, Zai CC, Cordes SP, Roder JC, Wong AH. Lee FH, et al. Mol Brain. 2013 Apr 30;6:20. doi: 10.1186/1756-6606-6-20. Mol Brain. 2013. PMID: 23631734 Free PMC article. - DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness.
Soares DC, Carlyle BC, Bradshaw NJ, Porteous DJ. Soares DC, et al. ACS Chem Neurosci. 2011 Nov 16;2(11):609-632. doi: 10.1021/cn200062k. Epub 2011 Aug 5. ACS Chem Neurosci. 2011. PMID: 22116789 Free PMC article. - Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness.
Johnstone M, Maclean A, Heyrman L, Lenaerts AS, Nordin A, Nilsson LG, De Rijk P, Goossens D, Adolfsson R, St Clair DM, Hall J, Lawrie SM, McIntosh AM, Del-Favero J, Blackwood DH, Pickard BS. Johnstone M, et al. Mol Neuropsychiatry. 2015 Oct;1(3):175-190. doi: 10.1159/000438788. Epub 2015 Oct 7. Mol Neuropsychiatry. 2015. PMID: 27239468 Free PMC article. - Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior.
Bolger GB, Smoot LHM, van Groen T. Bolger GB, et al. Int J Mol Sci. 2020 Aug 9;21(16):5704. doi: 10.3390/ijms21165704. Int J Mol Sci. 2020. PMID: 32784895 Free PMC article. - mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.
Dadalko OI, Siuta M, Poe A, Erreger K, Matthies HJ, Niswender K, Galli A. Dadalko OI, et al. J Neurosci. 2015 Jun 10;35(23):8843-54. doi: 10.1523/JNEUROSCI.0887-15.2015. J Neurosci. 2015. PMID: 26063917 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials